Celanese Stock (NYSE:CE), Trade Ideas

Celanese

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

Analyst Color

Upgrades

Price Target

Analyst Ratings

Shares of Celanese Corporation (NYSE: CE) maintained a downtrend in early trading on Monday.

Celanese Upgrade &#39;Reflects Progress&#39; As Debt Overhang Is Poised To Wane: Analyst

chemicals shutter

Equities

Large Cap

Mid Cap

Downgrades

Trading Ideas

Analyst bullish on commodity chemical stocks but selective, upgrades Dow Inc and Ecolab, downgrades Celanese and FMC Corp, lowers estimates for US chemicals stocks.

BofA Analyst&#39;s Chemical Blend: Rating Change Saga, Reassesses Agricultural Market Dynamics

News

Markets

General

Piper Sandler analyst Charles Neivert upgraded Celanese Corporation (NYSE: CE) to Neutral from Underweight,

Celanese Upgraded: Analyst Says &#34;Downside Risk Has Moderated&#34;

Celanese Corp

CE Energy Acquisition Corp.

CEA Industries Inc

Creations Inc

CEA Space Partners I Corp.

CENTRAL AUTOMOTIVE PRODS by Central Automotive Products Ltd.

Central Automotive Products Ltd

China Eastern Airlines Corp Ltd ADR

CHINA EVERBRIGHT BANK ORD by China Everbright Bank Co Ltd.

China Everbright Bank Co Ltd

CITYCHAMP WATCH & JEWELLE by Citychamp Watch & Jewellery Group Ltd.

Citychamp Watch & Jewellery Group Ltd

Cebu Air Inc

CANASIA ENERGY CORP by CANASIA ENERGY CORP.

CanAsia Energy Corp

Saltbae Capital Corp

Cecil Bancorp Inc

CECO Environmental Corp

Cedarlake Acquisition Corp

The Central and Eastern Europe Fund, Inc. (The) Common Stock

CENTRAL & EASTERN EUROPE FUND, INC.

Ceres Inc

CEEK VR

UpSnap Inc

Sprott Physical Gold and Silver Trust Units

Sprott Physical Gold and Silver Trust

Global X S&P Catholic Values Developed ex-U.S. ETF

CENTRAL FLA ST BK BELLEVW by Central Florida State Bank (Belleview FL)

Central Florida St Bank

COMML NATL FINCL CRP MICH by Commercial National Financial Corp (MI)

Commercial National Financial Corp (MI)

ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN

Exchange Listed Funds Trust ETF

Constellation Energy Corporation - Common Stock

Constellation Energy Corp

CHINA ED GROUP HLDGS LTD by CHINA ED GROUP HLDGS LTD.

China Education Group Holdings Ltd

CERRO GRANDE MINING CORP by Cerro Grande Mining Corp.

Cerro Grande Mining Corp

COSMO ENERGY HLDGS CO LTD by Cosmo Energy Hldgs Co Ltd

Cosmo Energy Holdings Co Ltd

Camber Energy Inc

COELACANTH ENERGY INC by COELACANTH ENERGY INC

Coelacanth Energy Inc

CONSOL Energy Inc

Cresco Ltd

Celsius

Celcuity Inc

Bristol-Myers Squibb Company Celegne Contingent Value Rights

Celsius Holdings Inc

CELLCOM ISRAEL LTD ORD by Cellcom Israel, Ltd.

Cellcom Israel Ltd

Cellframe

CELO - United States Dollar

Celer Network - United States Dollar

Centamin PLC

Celularity Inc

PREFERRED COMMERCE INC by Preferred Commerce Inc.

Preferred Commerce Inc

Celexpress Inc

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Technology Holdings Inc

ClearBridge MLP and Midstream Fund Inc. Common Stock

ClearBridge MLP & Midstream Fund Inc.

iShares J.P. Morgan EM Corporate Bond ETF

CEN Biotech Inc

Caravan Energy Corp Ordinary Shares

CareNet Inc

Cenntro Inc

CENNZnet

Central Garden & Pet Company - Common Stock

Central Garden & Pet Co

Central Garden & Pet Company - Class A Common Stock Nonvoting

Century Aluminum Co

CEO America Inc

CeCors Inc

Central Puerto S.A. American Depositary Shares (each represents ten Common Shares)

Central Puerto SA

Crestwood Equity Partners LP Unit Ltd Partnership Int (New)

Cerevel Therapeutics Holdings, Inc. - Common Stock

Cerevel Therapeutics Holdings Inc

Cere Network

CERES GLOBAL AG CORP ORD by Ceres Global Ag Corp.

Ceres Global Ag Corp

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings, Inc. - Warrants

Cerus Corp

Certara Inc

COLOMBIA ENERGY RESOUR by Colombia Energy Resources, Inc.

Colombia Energy Resources Inc

CES ENERGY SOLUTIONS ORD by CES Energy Solutions Corp.

CES Energy Solutions Corp

Chesser Resources Ltd

CHINESE ESTS HLDGS ORD by Chinese Estates Holdings Ltd.

Chinese Estates Holdings Ltd

CHINESE ESTS HLD UNSP/ADR by Chinese Estates Holdings Ltd.

CES Synergies Inc

Central Securities Corporation Common Stock

Central Securities Corp

CoinEx Token

CATHEDRAL ENERGY SVCS ORD by Cathedral Energy Services Ltd.

Cathedral Energy Services Ltd

DriveWealth NYSE 100 Index ETF

CAPITAL CITY ENERGY GROUP by Capital City Energy Group, Inc.

CYBER ENVIRO-TECH INC. by Cyber Enviro-Tech Inc.

Cyber Enviro-Tech Inc

CHINA ECOTOURISM GRP NEW by CHINA ECOTOURISM GROUP LTD.

Cetus Capital Acquisition Corp.

Cetus Capital Acquisition Corp. - Class A Common Stock

Cetus Capital Acquisition Corp

Cetus Capital Acquisition Corp. - Right to receive 1/6 of one share of Class A Common Stock

Cetus Capital Acquisition Corp. - Warrant

Cemtrex Inc

<p>RBC Capital  analyst Arun Viswanathan   maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Outperform and raises the price target from $165 to $171.</p>


RBC Capital Maintains Outperform on Celanese, Raises Price Target to $171

<p><strong>Celanese's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) short percent of float has fallen 7.03% since its last report. The company recently reported that it has <strong>4.94 million shares sold short</strong>, which is 6.88% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 7.75 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Celanese Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1712940323_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Celanese has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Celanese's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Celanese's peer group average for short interest as a percentage of float is 3.93%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

How Is The Market Feeling About Celanese?

<p>Citigroup  analyst Patrick Cunningham   maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Neutral and raises the price target from $150 to $167.</p>


Citigroup Maintains Neutral on Celanese, Raises Price Target to $167

<p>In the latest quarter, 11 analysts provided ratings for Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Celanese and provided 12-month price targets. The average target is $169.09, accompanied by a high estimate of $195.00 and a low estimate of $135.00. Marking an increase of 8.46%, the current average surpasses the previous average price target of $155.90. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1712667623_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The standing of Celanese among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$170.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$160.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$195.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$168.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$170.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Hassan Ahmed</td>
<td>Alembic Global</td>
<td>Announces</td>
<td>Neutral</td>
<td>$160.00</td>
<td>-</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$135.00</td>
<td>$124.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$169.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Celanese. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Celanese's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>For valuable insights into Celanese's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Celanese analyst ratings.</strong></a></p>
<h2>Delving into Celanese's Background</h2>
<p>Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.</p>
<h3>Celanese's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Celanese's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>9.41%</strong> as of 31 December, 2023, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Celanese's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>27.17%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Celanese's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>10.28%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Celanese's ROA excels beyond industry benchmarks, reaching <strong>2.68%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Celanese's debt-to-equity ratio surpasses industry norms, standing at <strong>1.99</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


A Closer Look at 11 Analyst Recommendations For Celanese

<p>Keybanc  analyst Aleksey Yefremov   maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Overweight and raises the price target from $176 to $190.</p>


Keybanc Maintains Overweight on Celanese, Raises Price Target to $190

<p>Barclays  analyst Michael Leithead   downgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Overweight to Equal-Weight and maintains the price target from $170 to $170.</p>


Barclays Downgrades Celanese to Equal-Weight, Maintains Price Target to $170

WIIM

Celanese shares are trading lower after JP Morgan downgraded the stock from Neutral to Underweight but raised its price target from $135 to $160.

<p>JP Morgan  analyst Jeffrey Zekauskas   downgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Neutral to Underweight and raises the price target from $135 to $160.</p>


JP Morgan Downgrades Celanese to Underweight, Raises Price Target to $160

<p>Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) has outperformed the market over the past 15 years by 4.05% on an annualized basis producing an average annual return of 17.22%. Currently, Celanese has a market capitalization of $19.17 billion. </p>
<p><strong>Buying $1000 In CE:</strong> If an investor had bought $1000 of CE stock 15 years ago, it would be worth <strong>$10,708.18</strong> today based on a price of $171.86 for CE at the time of writing.</p>
<h3>Celanese's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1711983625_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$1000 Invested In Celanese 15 Years Ago Would Be Worth This Much Today

<p>9 analysts have shared their evaluations of Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $168.44, along with a high estimate of $195.00 and a low estimate of $135.00. This upward trend is apparent, with the current average reflecting a 9.73% increase from the previous average price target of $153.50.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1711123213_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The perception of Celanese by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$195.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$168.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$170.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Hassan Ahmed</td>
<td>Alembic Global</td>
<td>Announces</td>
<td>Neutral</td>
<td>$160.00</td>
<td>-</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$135.00</td>
<td>$124.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$169.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$176.00</td>
<td>$150.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Celanese. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Celanese's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Celanese's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Celanese analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Celanese</h2>
<p>Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.</p>
<h3>Financial Insights: Celanese</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Celanese's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of <strong>9.41%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Celanese's net margin excels beyond industry benchmarks, reaching <strong>27.17%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Celanese's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>10.28%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Celanese's ROA excels beyond industry benchmarks, reaching <strong>2.68%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>1.99</strong>, Celanese faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


9 Analysts Assess Celanese: What You Need To Know

<p>Wells Fargo  analyst Michael Sison   maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Overweight and raises the price target from $180 to $195.</p>


Wells Fargo Maintains Overweight on Celanese, Raises Price Target to $195

Celanese and Secarna Pharmaceuticals Enter RNA Research Collaboration For Long-Acting Antisense Therapies

<p>Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) has outperformed the market over the past 15 years by 4.98% on an annualized basis producing an average annual return of 17.91%. Currently, Celanese has a market capitalization of $17.18 billion. </p>
<p><strong>Buying $1000 In CE:</strong> If an investor had bought $1000 of CE stock 15 years ago, it would be worth <strong>$13,604.10</strong> today based on a price of $157.76 for CE at the time of writing.</p>
<h3>Celanese's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1710511214_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Here's How Much $1000 Invested In Celanese 15 Years Ago Would Be Worth Today

<p><strong>Celanese's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) short percent of float has fallen 3.78% since its last report. The company recently reported that it has <strong>5.58 million shares sold short</strong>, which is 5.85% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 8.87 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Celanese Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1709916315_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Celanese has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Celanese's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Celanese's peer group average for short interest as a percentage of float is 3.65%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


<p>Today, March 05, 2024, <b>Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)</b> will distribute a dividend payout of $0.70 per share, highlighting an annualized dividend yield of 1.89%. Shareholders who owned the stock before the ex-dividend date on February 16, 2024 will be eligible for this payout.</p>
<h3>Celanese Recent Dividend Payouts</h3>
<style>
        table {
            width: 100%;
            border-collapse: collapse;
            font-family: Arial, sans-serif;
            font-size: 14px;
        }

        th, td {
            padding: 8px;
            text-align: left;
        }

        th {
            background-color: #293a5a;
            color: #fff;
            text-align: left;
        }

        tr:nth-child(even) {
            background-color: #f2f4f8;
        }

        tr:hover {
            background-color: #e1e4ea;
        }

        td:nth-child(3), td:nth-child(5) {
            text-align: left;
        }

        .dividend-amount {
            font-weight: bold;
            color: #0d6efd;
        }

        .dividend-frequency {
            font-size: 12px;
            color: #6c757d;
        }
    </style><table>
<thead>
<tr>
<th><strong>Ex-Date</strong></th>
<th style="text-align: right;"><strong>Payments per year</strong></th>
<th><strong>Dividend</strong></th>
<th><strong>Yield</strong></th>
<th><strong>Announced</strong></th>
<th><strong>Record</strong></th>
<th><strong>Payable</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>2024-02-16</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>1.89%</td>
<td>2024-02-07</td>
<td>2024-02-20</td>
<td>2024-03-05</td>
</tr>
<tr>
<td>2023-10-27</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>2.29%</td>
<td>2023-10-18</td>
<td>2023-10-30</td>
<td>2023-11-13</td>
</tr>
<tr>
<td>2023-07-28</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>2.26%</td>
<td>2023-07-19</td>
<td>2023-07-31</td>
<td>2023-08-14</td>
</tr>
<tr>
<td>2023-04-28</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>2.56%</td>
<td>2023-04-19</td>
<td>2023-05-01</td>
<td>2023-05-15</td>
</tr>
<tr>
<td>2023-02-17</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>2.26%</td>
<td>2023-02-08</td>
<td>2023-02-21</td>
<td>2023-03-07</td>
</tr>
<tr>
<td>2022-10-28</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>2.95%</td>
<td>2022-10-19</td>
<td>2022-10-31</td>
<td>2022-11-14</td>
</tr>
<tr>
<td>2022-07-22</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>2.44%</td>
<td>2022-07-13</td>
<td>2022-07-25</td>
<td>2022-08-08</td>
</tr>
<tr>
<td>2022-04-27</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>1.87%</td>
<td>2022-04-19</td>
<td>2022-04-28</td>
<td>2022-05-12</td>
</tr>
<tr>
<td>2022-02-18</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>1.72%</td>
<td>2022-02-09</td>
<td>2022-02-22</td>
<td>2022-03-08</td>
</tr>
<tr>
<td>2021-10-29</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>1.65%</td>
<td>2021-10-20</td>
<td>2021-11-01</td>
<td>2021-11-15</td>
</tr>
<tr>
<td>2021-07-23</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>1.76%</td>
<td>2021-07-14</td>
<td>2021-07-26</td>
<td>2021-08-09</td>
</tr>
<tr>
<td>2021-04-23</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>1.79%</td>
<td>2021-04-14</td>
<td>2021-04-26</td>
<td>2021-05-10</td>
</tr>
</tbody>
</table>
<p>Celanese's dividend yield falls in the middle range when compared to its industry peers, with <b>Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>)</b> having the highest annualized dividend yield at 3.67%.</p>
<h3>Analyzing Celanese Financial Health</h3>
<p>Companies that pay out steady cash dividends are attractive to income-seeking investors, and companies that are financially healthy tend to maintain their dividend payout schedule. For this reason, investors can find it insightful to see if a company has been increasing or decreasing their dividend payout schedule and if their earnings are growing. </p>
<h3>YoY Growth in Dividend Per Share</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1709651116_0.png" alt="dividend chart graph" /></p>
<p>During the period of 2020 to 2023, the company experienced a notable growth in its dividend per share. The dividend per share increased from $2.48 to $2.80, reflecting the company's focus on providing greater returns to its shareholders.</p>
<h3>YoY Earnings Growth For Celanese</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1709651116_1.png" alt="earning chart graph" /></p>
<p>From 2020 to 2023, Celanese experienced a growth in earnings per share, with an increase from $7.53 to $8.12. This positive earnings trend indicates the company's potential to enhance their cash dividend payout, which can benefit income-seeking investors.</p>
<h3>Recap</h3>
<p>This article provides an in-depth analysis of Celanese's recent dividend distribution and the impact it has on shareholders. The company is currently distributing a dividend of $0.70 per share, resulting in an annualized dividend yield of 1.89%.</p>
<p>Celanese's dividend yield falls in the middle range when compared to its industry peers, with Eastman Chemical having the highest annualized dividend yield at 3.67%.</p>
<p>The upward trend in dividend per share and earnings per share for Celanese from 2020 to 2023 reflects a strong financial position, supporting the company's ability to consistently distribute profits to their investors.</p>
<p>To remain updated on any changes in financials or dividend disbursements, investors should closely observe the company's performance in the coming quarters.</p>
<p>\To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar. </p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Dividends

Celanese Demonstrates Strong Performance and Increased Profits, Maximizing Returns for Shareholders

<p>Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) has outperformed the market over the past 15 years by 6.8% on an annualized basis producing an average annual return of 21.02%. Currently, Celanese has a market capitalization of $16.29 billion. </p>
<p><strong>Buying $1000 In CE:</strong> If an investor had bought $1000 of CE stock 15 years ago, it would be worth <strong>$16,241.87</strong> today based on a price of $149.59 for CE at the time of writing.</p>
<h3>Celanese's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1709134225_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today

<p>Shares of <strong>Celanese Corporation </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ce#NYSE">CE</a>) maintained a <a href="https://www.benzinga.com/quote/CE">downtrend in early trading on Monday</a>.</p>
<p>This is likely to be a &ldquo;critical transition year&rdquo; for the company, when the sizable overhang of the debt taken for the M&amp;M transaction is reduced, according to Piper Sandler.</p>
<p><strong>The Celanese Analyst: </strong>Charles Neivert upgraded the rating for Celanese from Neutral to Overweight, while raising the price target from $135 to $170.</p>
<p><strong>The Celanese Thesis:</strong> &ldquo;The upgrade reflects the progress on earnings and debt we see coming in 2024 and showing more strongly in 2025 (and beyond),&rdquo; Neivert said in an upgrade note.</p>
<p><em>Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.</em></p>
<p>Although Celanese&rsquo;s earnings recovery and balance sheet reconstruction will take time, the economic environment and industry dynamics are becoming more positive, as a result of which the shares could &ldquo;move more with the improving business cycle and be less concerned with the debt risk,&rdquo; the analyst stated.</p>
<p>Celanese&rsquo;s EBITDA may rise to just below $3 billion in 2025, &ldquo;on a modest recovery in global markets, increasing contributions from transaction synergies and stronger throughput from capacity gains in 2024 which should ramp to full operation and contribution in 2025,&rdquo; he added.</p>
<p><strong>CE Price Action: </strong>Shares of Celanese had risen slightly by 0.01% to $149.40 at the time of publication Monday.</p>
<p>&nbsp;</p>


Celanese Upgrade 'Reflects Progress' As Debt Overhang Is Poised To Wane: Analyst

<p>RBC Capital  analyst Arun Viswanathan   maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Outperform and lowers the price target from $168 to $165.</p>


RBC Capital Maintains Outperform on Celanese, Lowers Price Target to $165

<p>Piper Sandler  analyst Charles Neivert   upgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Neutral to Overweight and raises the price target from $135 to $170.</p>


Piper Sandler Upgrades Celanese to Overweight, Raises Price Target to $170

<p>Analysts' ratings for Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) over the last quarter vary from bullish to bearish, as provided by 8 analysts.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $162.5, a high estimate of $180.00, and a low estimate of $135.00. This current average reflects an increase of 11.63% from the previous average price target of $145.57. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1708621223_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Celanese. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Hassan Ahmed</td>
<td>Alembic Global</td>
<td>Announces</td>
<td>Neutral</td>
<td>$160.00</td>
<td>-</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$135.00</td>
<td>$124.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$169.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$176.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$169.00</td>
<td>$144.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$145.00</td>
<td>$130.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Celanese. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Celanese compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Celanese's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Celanese's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Celanese analyst ratings.</strong></a></p>
<h2>Delving into Celanese's Background</h2>
<p>Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.</p>
<h3>Key Indicators: Celanese's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Celanese's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately <strong>-5.66%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Celanese's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>27.17%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Celanese's ROE excels beyond industry benchmarks, reaching <strong>10.28%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Celanese's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.68%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Celanese's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>1.98</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Celanese Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)

Vltava Fund Q1 2024 Letter To Shareholders

In a report released yesterday, Michael Sison from Wells Fargo maintained a Buy rating on Celanese (CE – Research Report), with a price target of $...